San Francisco, 28
January, Orthobiologics Market Analysis By Product (DBM, Allograft, BMP,
Viscosupplementation, Synthetic Bone Substitutes, Stem Cell), By Application
(Spinal Fusion, Reconstructive Surgery, Trauma Repair), By End Use, And Segment
Forecasts, 2018 – 2025
The
global orthobiologics market is expected to reach USD 10.2 billion by 2025,
according to a new study by Grand View Research, Inc. The orthobiologics market
is predominantly driven by the increasing orthopedic disease and
musculoskeletal disease burden globally. Moreover, emerging technological
innovations in biomaterials, used in the production of orthobiologics are
presumed to accelerate the market demand over the forecast period. These
predominantly include modifications in graft designs, advent of recombinant
biologic agents, stem cell therapy and cultured tissue scaffolds.
These advancements are
accompanied with the benefits such as enhanced biocompatibility, reduced
surgical time and smaller incisions. Furthermore, these novel solutions are
presumed to efficiently reduce the recurrence of post-operative complications,
which in turn is expected to boost the orthobiologics market during the
forecast period.
Access Full Research
Report On Orthobiologics Analysis:
Further Key Findings From the Study Suggest:
·
In 2015, viscosupplementation
accounted for the largest share in the product segment owing to being a cost
efficient therapeutic alternative for symptomatic management of osteoarthritis
·
Spinal fusion held the largest
share in the application segment in 2015, owing to presence of third party
insurers and reimbursement structure for fusion enhancement products thus
triggering growth
·
In 2015, North America
accounted for the dominant share owing to consistent efforts of industry
players in promoting awareness pertinent to the orthobiological products
resulting in significant rise in adoption rate
·
Asia Pacific is anticipated to
exhibit an exponential CAGR as a consequence of significant surge in healthcare
spending and awareness levels with respect to the availability of
orthobiologics
·
The prominent players are
consistently indulging into extensive strategies to gain competitive position
including regional expansion and mergers & acquisitions to capture a
greater market share
·
For instance, in November 2015,
Bioventus acquired BioStructures, a bioabsorbable bone graft developer. This
acquisition was carried out to expand orthobiologics product portfolio and
grafting solutions in order to expand their market share
Browse More Reports Of This Category By
Grand View Research At: www.grandviewresearch.com/industry/biotechnology
Grand View Research has segmented the
orthobiologics market on the basis of product, application, end use, and
region:
Orthobiologics Product Outlook
(Revenue, USD Billion, 2014 - 2025)
·
Demineralized Bone Matrix(DBM)
·
Allograft
·
Bone Morphogenetic Protein
(BMP)
·
Viscosupplementation
·
Synthetic Bone Substitutes
·
Stem Cell Therapy
Orthobiologics Application
Outlook (Revenue, USD Billion, 2014 - 2025)
·
Spinal Fusion
·
Trauma Repair
·
Reconstructive Surgery
Orthobiologics End-use Outlook
(Revenue, USD Billion, 2014 - 2025)
·
Hospitals
·
Orthopedic Clinics
Orthobiologics Regional Outlook
(Revenue, USD Billion, 2014 - 2025)
·
North America
o
U.S
o
Canada
·
Europe
o
Germany
o
UK
·
Asia Pacific
o
Japan
o
China
o
India
·
Latin America
o
Brazil
o
Mexico
·
Middle East and Africa
o
South Africa
Access Full Press Release of this Report: www.grandviewresearch.com/press-release/global-orthobiological-market
About Grand View Research
Grand View Research provides
syndicated as well as customized research reports and consulting services on 46
industries across 25 major countries worldwide. This U.S.-based market research
and consulting company is registered in California and headquartered in San
Francisco. Comprising over 425 analysts and consultants, the company adds 1200+
market research reports to its extensive database each year. Supported by an
interactive market intelligence platform, the team at Grand View Research
guides Fortune 500 companies and prominent academic institutes in comprehending
the global and regional business environment and carefully identifying future
opportunities.
For more information: www.grandviewresearch.com/
No comments:
Post a Comment